Sinohealth (HKG:2361) expects a 36% to 46% decline in attributable profit for the six months ended June 30 from 41.7 million yuan a year prior, a Wednesday Hong Kong bourse filing said.
The healthcare solutions provider attributed the anticipated lower profit mainly to an increased investment in AI R&D, lower government subsidies received, higher exchange losses, and reduced interest income.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments